… have died from COVID-19. In peripheral blood mononuclear cells, active NLRP3 inflammasome
was observed and was associated with disease severity in COVID-19 patients [3]. In …

… priming of NLRP3 inflammasome through … NLRP3 inflammasome has also been proposed
to play a role in the pathogenesis COVID-19, but data on the role of these inflammasomes …

… As insight is gained into the clinical phenotypes associated with COVID-19, we propose
NLRP3 as therapeutic target warranting rapid investigation in clinical trials highlighting car…

… 3 (NLRP3) inflammasome pathway activation is partly responsible for the inflicted damages
in both COVID-19 … is on NLRP3 inflammasome in the pathogenesis of COVID-19 infection …

… the murine coronavirus mouse hepatitis virus (MHV) activated the NLRP3 inflammasome
and … Deleting NLRP3 inflammasome components or the downstream cell death executioner …

… This NLRP3 over-activated status in elderly individuals, is also … the NLRP3 inflammasome
plays a central role in the increased lethality observed in elderly patients infected by COVID-19…

… from severe COVID-19 patients display increased NLRP3-I … COVID-19 patients have
increased levels of activated NLRP3-I … which SARS-CoV-2 activates the NLRP3-I is imperative for …

… CXCL9 is a monokine, induced by interferon, which increases lymphocytic infiltration, 3
and which is implicated in NLRP3 inflammasome activation. Adequate sleep also ensures the …

… of an unbalanced NLRP3 inflammasome response to the … severe COVID‐19: in relatively
recent times, some authors have highlighted how the activation of the NLRP3 inflammasome is …

… -containing 3 (NLRP3) inflammasome activation is beneficial … that has caused the coronavirus
2019 (COVID-19) pandemic. … immune responses, inflammasome activation, inflammatory …